Bi-weekly administration of pegylated liposomal doxorubicin plus paclitaxel in metastatic breast cancer (MBC) patients: A phase II study

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 844-844 ◽  
Author(s):  
E. Simoncini ◽  
V. D. Ferrari ◽  
V. Amoroso ◽  
F. Valcamonico ◽  
S. Grisanti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Weekly Administration

scholarly journals Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

2012 ◽  
Vol 23 (10) ◽  
pp. 2599-2605 ◽  
Author(s):  
R.P. Collea ◽  
F.W. Kruter ◽  
J.E. Cantrell ◽  
T.K. George ◽  
S. Kruger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin

scholarly journals Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

2010 ◽  
Vol 10 (6) ◽  
pp. 465-470 ◽  
Author(s):  
William J. Irvin ◽  
Robert Z. Orlowski ◽  
Wing-Keung Chiu ◽  
Lisa A. Carey ◽  
Frances A. Collichio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin
Sign in / Sign up

Export Citation Format

Share Document